Activation and homologous desensitization of human endothelial cells by CD40 ligand, tumor necrosis factor, and interleukin 1

Journal of Experimental Medicine

Volumn 184, Issue 1, 1996, Pages 173-182

  Karmann, Karin ^a   Min, Wang ^a   Fanslow, William C ^b   Pober, Jordan S ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b AMGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GLYCOPROTEIN GP 39; INTERCELLULAR ADHESION MOLECULE 1; RECOMBINANT CD40 LIGAND; RECOMBINANT INTERLEUKIN 1; RECOMBINANT TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ARTICLE; CONTROLLED STUDY; DESENSITIZATION; DRUG POTENCY; ELECTROPHORETIC MOBILITY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IMMUNOMODULATION; LIGAND BINDING; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; UMBILICAL VEIN;

BASE SEQUENCE; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CD40 LIGAND; CELL ADHESION MOLECULES; E-SELECTIN; ENDOTHELIUM, VASCULAR; GENE EXPRESSION; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-1; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MEMBRANE GLYCOPROTEINS; MITOGEN-ACTIVATED PROTEIN KINASES; MOLECULAR SEQUENCE DATA; OLIGODEOXYRIBONUCLEOTIDES; RNA, MESSENGER; TRANSCRIPTION, GENETIC; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR CELL ADHESION MOLECULE-1;

EID: 0030054637     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.184.1.173     Document Type: Article

References (71)

1. Bevilacqua, M.P. 1993. Endothelial-leukocyte adhesion molecules. Annu. Rev. Immunol. 11:767-804.
2. Pober, J.S., M.P. Bevilacqua, D.L. Mendrick, L.A. Lapierre, W. Fiers, and M.A. Gimbrone, Jr. 1986. Two distinct monokines, interleukin 1 and tumor necrosis factor, each independently induce biosynthesis and transient expression of the same antigen on the surface of cultured human vascular endothelial cells. J. Immunol. 136:1680-1687.
3. Bevilacqua, M.P., J.S. Pober, D.L. Mendrick, R.S. Cotran, and M.A. Gimbrone, Jr. 1987. Identification of an inducible endothelial leukocyte adhesion molecule, ELAM-1. Proc. Natl. Acad. Sci. USA. 84:9238-9242.
4. Lawrence, M.B., D.F. Bainton, and T.A. Springer. 1994. Neutrophil tethering to and rolling on E-selectin are separable by requirement for L-selectin. Immunity. 1:137-145.
5. Olofsson, A.M., K.E. Arfors, L. Ramezani, B.A. Wolitzky, E.C. Butcher, and U.H. von Andrian. 1994. E-selectin mediates leukocyte rolling in interleukin-1-treated rabbit mesentery venules. Blood. 84:2749-2758.
6. Rice, G.E., and M.P. Bevilacqua. 1989. An inducible endothelial cell surface glycoprotein mediates melanoma adhesion. Science (Wash. DC). 246:1303-1306.
7. Rice, G.E., J.M. Munro, and M.P. Bevilacqua. 1990. Inducible cell adhesion molecule 110 (INCAM-110) is an endothelial receptor for lymphocytes. A CD11/CD18-independent adhesion mechanism. J. Exp. Med. 171:1369-1374.
8. Berlin, C., R.F. Bargatze, J.J. Campbell, U.H. von Andrian, M.C. Szabo, S.R. Hasslen, R.D. Nelson, E.L. Berg, S.L. Erlandsen, and E.G. Butcher. 1995. alpha 4 integrins mediate lymphocyte attachment and rolling under physiologic flow. Cell. 80:413-422.
9. + T lymphocytes on tumor necrosis factor α-activated vascular endothelium under flow. J. Exp. Med. 181:1179-1186.
10. Cybulsky, M., and M. Gimbrone. 1991. Endothelial expression of a mononuclear leukocyte adhesion molecule during artherogenesis. Science (Wash. DC). 251:788-791.
11. Pober, J.S., M.A. Gimbrone Jr., L.A. Lapierre, D.L. Mendrick, W. Fiers, R. Rothlein, and T.A. Springer. 1986. Overlapping patterns of activation of human endothelial cells by interleukin 1, tumor necrosis factor, and immune interferon. J. Immunol. 137:1893-1896.
12. Lawrence, M.B., and T.A. Springer. 1991. Leukocytes roll on a selectin at physiologic flow rates: distinction from and prerequisite for adhesion through integrins. Cell. 65:859-873.
13. Smith, C.W., R. Rothlein, B.J. Hughes, M.M. Mariscalco, H.E. Rudloff, F.C. Schmalstieg, and D.C. Anderson. 1988. Recognition of an endothelial determinant for CD18-dependent human neutrophil adherence and transendothelial migration. J. Clin. Invest. 82:1746-1756.
14. Oppenheimer-Marks, N., L.S. Davis, D. Tompkins Bogue, J. Ramberg, and P.E. Lipsky. 1991. Differential utilization of ICAM-1 and VCAM-1 during the adhesion and transendothelial migration of human T lymphocytes. J. Immunol. 147: 2913-2921.
15. Slowik, M.R., L.G. De Luca, W. Fiers, and J.S. Pober. 1993. Tumor necrosis factor activates human endothelial cells through the p55 tumor necrosis factor receptor but the p75 receptor contributes to activation at low tumor necrosis factor concentration. Am. J. Pathol 143:1724-1730.
16. Pober, J.S., L.A. Lapierre, A.M. Stolpen, T.A. Brock, T.A. Springer, W. Fiers, M.P, Bevilacqua, D.L. Mendrick, and M.A. Gimbrone, Jr. 1987. Activation of cultured human endothelial cells by recombinant lymphotoxin: comparison with tumor necrosis factor and interleukin 1 species. J. Immunol. 138:3319-3324.
17. Munro, J.M., J.S. Pober, and R.S. Cotran. 1989. Tumor necrosis factor and interferon-γ induce distinct patterns of endothelial activation and associated leukocyte accumulation in skin of Papio anubis. Am. J. Pathol. 135:121-133.
18. Munro, J.M., J.S. Pober, and R.S. Cotran. 1991. Recruitment of neutrophils in the local endotoxin response: association with de novo endothelial expression of endothelial leukocyte adhesion molecule-1. Lab. Invest. 64:295-299.
19. + T cell infiltration. J. Immunol. 149:2954-2960.
20. Dumonde, D.C., M.S. Pulley, F.J. Paradinas, B.M. Southcott, D. O'Connell, M.R.G. Robinson, F. Den Hollander, and A.H. Schuurs. 1982. Histological features of skin reactions to human lymphoid cell line lymphokine in patients with advanced cancer. J. Pathol. 138:289-308.
21. Waldorf, H.A., L.J. Walsh, N.M. Schechter, and G.F. Murphy. 1991. Early cellular events in evolving cutaneous delayed hypersensitivity in humans. Am. J. Pathol. 138:477-486.
22. Whelan, J., P. Ghersa, R. Hooft van Huijsduijnen, J. Gray, G. Chandra, F. Talabot, and J.F. DeLamarter. 1991. An NF-κB-like factor is essential but not sufficient for cytokine induction of endothelial leukocyte adhesion molecule 1 (ELAM-1) gene transcription. Nucleic Acids Res. 19:2645-2653.
23. Bender, J.R., M.M. Sadeghi, C. Watson, S. Pfau, and R. Pardi. 1994. Heterogenous activation thresholds to cytokines in genetically distinct endothelial cells: evidence for diverse transcriptional responses. Proc. Natl. Acad. Sci. USA. 91: 3994-3998.
24. Hou, J., V. Baichwal, and Z. Cao. 1994. Regulatory elements and transcription factors controlling basal and cytokine-induced expression of the gene encoding ICAM-1. Proc. Natl. Acad. Sci. USA. 91:1641-1645.
25. Johnson, D.R., A. Jahnke, S. Ghosh, and J.S. Pober. 1996. A sustained reduction in 1κB-β may contribute to persistent NF-κB activation in human endothelial cells. J. Biol. Chem. In press.
26. Hooft van Huijsduijnen, R., J. Whelan, R. Pescini, M. Becker-André, A.-M. Schenk, and J.F. DeLamarter. 1992. A T-cell enhancer cooperates with NF-κB to yield cytokine induction of E-selectin gene transcription in endothelial cells. J. Biol. Chem. 267:22385-22391.
27. Kaszubska, W., R. Hooft van Huijsduijnen, P. Ghersa, A.-M. DeRaemy-Schenk, B.P.C. Chen, T. Hai, J.F. DeLamarter, and J. Whelan. 1993. Cyclic AMP-independent ATF family members interact with NF-κB and function in the activation of the E-selectin promotor in response to cytokines. Mol. Cell. Biol. 13:7180-7190.
28. De Luca, L.G., D.R. Johnson, M.Z. Whitley, T. Collins, and J.S. Pober. 1994. cAMP and Tumor Necrosis Factor competitively regulate transcriptional activation through nuclear factor binding to the cAMP-responsive element/activating transcription factor element of the endothelial leukocyte adhesion molecule-1 (E-selectin) promoter. J. Biol. Chem. 269:19193-19196.
29. Reimold, A.M., M.J. Grusby, B. Kosaras, J.W.U. Fries, R. Mori, S. Maniwa, I.M. Clauss, T. Collins, R.L. Sidman, M.J. Glimcher, and L.H. Glimcher. 1996. Chondrodysplasia and neurological abnormalities in ATF-2-deficient mice. Nature (Lond.). 379:262-265.
30. van Dam, H., M. Duyndam, R. Rottier, A. Bosch, L. de Vries-Smits, P. Herrlich, A. Zantema, P. Angel, and A.J. Van der Eb. 1993. Heterodimer formation of c-Jun and ATF-2 is responsible for induction of c-jun by the 243 amino acid adenovirus E1A protein. EMBO (Eur. Mol. Biol. Organ.) J. 12: 479-487.
31. Gupta, S., D. Campbell, B. Dérijard, and R.J. Davis. 1995. Transcription factor ATF2 regulation by the JNK signal transduction pathway. Science (Wash DC). 267:389-393.
32. Shu, H.B., A.B. Agranoff, E.G. Nabel, K. Leung, C.S. Duckett, A.S. Neish, T. Collins, and G. Nabel. 1993. Differential regulation of vascular cell adhesion molecule 1 gene expression by specific NF-κB subunits in endothelial and epithelial cells. Mol. Cell. Biol. 13:6283-6289.
33. Neish, A.S., M.A. Read, D. Thanos, R. Pine, T. Maniatis, and T. Collins. 1995. Endothelial IRF-1 cooperates with NF-κB as a transcriptional activator of vascular cell adhesion molecule-1. Mol. Cell. Biol. 15:2558-2569.
34. Johnson, D.J., and J.S. Pober. 1994. HLA Class I heavy-chain gene promotor elements mediating synergy between tumor necrosis factor and interferons. Mol. Cell. Biol. 14:1322-1332.
35. Karmann, K., C.C.W. Hughes, J. Schechner, W.C. Fanslow, and J.S. Pober. 1995. CD40 on human endothelial cells: inducibility by cytokines and functional regulation of adhesion molecule expression. Proc. Natl. Acad. Sci. USA. 92:4342-4346.
36. Hollenbaugh, D., N. Mischel-Petty, C.P. Edwards, J.C. Simon, R.W. Denfeld, P.A. Kiener, and A. Aruffo. 1995. Expression of functional CD40 by vascular endothelial cells. J. Exp. Med. 182:33-40.
37. Yellin, M.J., J. Brett, D. Baum, A. Matsushima, M. Szabolcs, D. Stern, and L. Chess. 1995. Functional interactions of T cells with endothelial cells: the role of CD40L-CD40-mediated signals. J. Exp. Med. 182:1857-1864.
38. Fanslow, W.C., S. Srinivasan, R. Paxton, M.G. Gibson, M.K. Spriggs, and R.J. Armitage. 1994. Structural characteristics of CD40 ligand that determine biological function. Sem. Immunol. 6:267-278.
39. Spriggs, M.K., R.J. Armitage, L. Strockbine, K.N. Clifford, B.M. Macduff, T.A. Sato, C.R. Maliszewski, and W.C. Fanslow. 1992. Recombinant human CD40 ligand stimulates B cell proliferation and immunoglobulin E secretion. J. Exp. Med. 176:1543-1550.
40. Gimbrone, M.A., Jr. 1976. Culture of vascular endothelium. Prog. Hemostasis Thromb. 3:1-28.
41. Thornton, S.C., S.N. Mueller, and E.M. Levine. 1983. Human endothelial cells: use of heparin in cloning and longterm serial culture. Science (Wash. DC). 222:623-625.
42. Ledebur, H.C., and T.P. Parks. 1995. Transcriptional regulation of the intercellular adhesion molecule-1 gene by inflammatory cytokines in human endothelial cells. J. Biol. Chem. 270:933-943.
43. Jamieson, C., P.G. McCaffrey, A. Rao, and R. Sen. 1991. Physiologic activation of T cells via the T cell receptor induces NFκB. J. Immunol. 147:416-420.
44. Rauscher III, F.J., P.J. Voulalas, B.R. Franza Jr., and T. Curran. 1988. Fos and Jun bind cooperatively to the AP-1 site: reconstitution in vitro. Genes Dev. 2:1687-1699.
45. Min, W., S. Ghosh, and P. Lengyel. 1996. The interferon-inducible p202 protein as a modulator of transcription: inhibition of NF-κB, c-Fos, and c-jun activities. Mol. Cell. Biol. 16:359-368.
46. Smith, D.B., and K.S. Johnson. 1988. Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase. Gene (Amst.). 67:31-40.
47. Hibi, M., A. Lin, T. Smeal, A. Minden, and M. Karin. 1993. Identification of an oncoprotein- and uv-responsive protein kinase that binds and potentiates the c-jun activation domain. Genes Dev. 7:2135-2148.
48. Laemmli, U.K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (Lond.). 227:680-685.
49. Schindler, U., and V.R. Baichwal. 1994. Three NF-κB binding sites in the human E-selectin gene required for maximal tumor necrosis factor alpha-induced expression. Mol. Cell. Biol. 14:1322-1332.
50. Jahnke, A., and J.P. Johnson. 1994. Synergistic activation of intercellular adhesion molecule 1 (ICAM-1) by TNFα and IFN-γ is mediated by p65/p50 and p65/c-rel and interferon-responsive factor Stat1α (p91) that can be activated by both IFN-γ and IFN-α. FEBS Lett. 354:220-226.
51. Mansky, P., W.M. Brown, J.-H. Park, J.W. Choi, and S.Y. Yang. 1994. The second κB element κB2, of the HLA-A class I regulatory complex is an essential part of the promotor. J. Immunol. 153:5082-5090.
52. Bevilacqua, M.P., J.S. Pober, G.R. Majeau, W. Fiers, R.S. Cotran, and M.A. Gimbrone. 1986. Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: characterization and comparison with the actions of interleukin 1. Proc. Natl. Acad. Sci. USA. 83: 4533-4537.
53. Armitage, R.J., W.C. Fanslow, L. Strockbine, T.A. Sato, K.N. Clifford, B.M. Macduff, D.M. Anderson, S.D. Gimpel, T. Davis-Smith, C.R. Maliszewski, et al., 1992. Molecular and biological characterization of a murine ligand for CD40. Nature (Lond.). 357:80-82.
54. Hollenbaugh, D., L.S. Grosmaire, C.D. Kullas, N.J. Chalupny, S. Braesch-Andersen, R.J. Noelle, I. Stamenkovic, J.A. Ledbetter, and A. Aruffo. 1992. The human T cell antigen gp39, a member of the TNF gene family, is a ligand for the CD40 receptor: expression of a soluble form of gp39 with B cell co-stimulatory activity. EMBO (Eur. Mol. Biol. Organ.) J. 11:4313-4321.
55. Grell, M., E. Douni, H. Wajant, M. Löhden, M. Clauss, B. Maxeiner, S. Georgopoulos, W. Lesslauer, G. Kollias, K. Pfizenmaier, and P. Scheurich. 1995. The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor. Cell. 83:793-802.
56. Hsu, H., J. Xiong, and D.V. Goeddel. 1995. The TNF Receptor 1-associated protein TRADD signals cell death and NF-κB activation. Cell. 81:495-504.
57. Hsu, H., H.-B. Shu, M.-G. Pan, and D.V. Goeddel. 1996. TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell. 84:299-308.
58. Rothe, M., M.-G. Pan, W.J. Henzel, T.M. Ayres, and D.V. Goeddel. 1995. The TNFR2-TRAF signaling complex contains two novel prtoeins related to baculoviral inhibitor of apoptosis proteins. Cell. 83:1243-1252.
59. Rothe, M., V. Sarma, V.M. Dixit, and D.V. Goeddel. 1995. TRAF2-mediated activation of NF-κB by TNF receptor 2 and CD40. Science (Wash. DC). 269:1424-1427.
60. Mackay, F., H. Loetscher, D. Stueber, G. Gehr, and W. Lesslauer. 1993. Tumor necrosis factor α (TNF-α)-induced cell adhesion to human endothelial cells is under dominant control of one TNF receptor type, TNF-R55. J. Exp. Med. 177: 1277-1286.
61. Hu, H.M., K. O'Rourke, M.S. Boguski, and V.M. Dixit. 1994. A novel RING finger protein interacts with the cytoplasmic domain of CD40. J. Biol. Chem. 269:30069-30072.
62. Cheng, G., A.M. Cleary, Z.-S. Ye, D.I. Hong, S. Lederman, and D. Baltimore. 1995. Involvement of CRAF1, a relative of TRAF, in CD40 signaling. Science (Wash. DC). 267:1494-1498.
63. Thieme, T.R., S.H. Hefeneider, C.R. Wagner, and D.R. Burger. 1987. Recombinant murine and human IL 1α bind to human endothelial cells with an equal affinity, but have unequal ability to induce endothelial cell adherence of lymphocytes. J. Immunol. 139:1173-1178.
64. Cozzolino, F., M. Torcia, M. Lucibello, L. Morbidelli, M. Ziehe, J. Platt, S. Fabiani, J. Brett, and D. Stern. 1993. Interferon-α and interleukin 2 synergistically enhance basic fibroblast growth factor synthesis and induce release, promoting endothelial cell growth. J. Clin. Invest. 91:2504-2512.
65. Bertini, R., M. Sironi, I. Martin-Padura, F. Colotta, S. Rambaldi, S. Bernasconi, P. Ghezzi, S.J. Haskill, D. Liu, and A. Mantovani. 1992. Inhibitory effect of recombinant intracellular Interleukin 1 receptor antagonist on endothelial cell activation. Cytokine. 4:44-47.
66. Cao, Z., W.J. Henzel, and X. Gao. 1996. IRAK: A kinase associated with the interleukin-1 receptor. Science (Wash. DC). 271:1128-1131.
67. Minden, A., A. Lin, M. McMahon, C. Lange-Carter, B. Dérijard, R.J. Davis, G.L. Johnson, and M. Karin. 1994. Differential activation of ERK and JNK mitogen-activated protein kinases by Raf-1 and MEKK. Science (Wash. DC). 266: 1719-1722.
68. Opipari, Jr, A.W., H.M. Hu, R. Yabkowitz, and V.M. Dixit. 1992. The A20 zinc finger protein protects cells from tumor necrosis factor cytotoxicity. J. Biol. Chem. 267:12424-12427.
69. Krikos, A., L.C. D., and V.M. Dixit. 1992. Transcriptional activation of the tumor necrosis factor alpha-inducible zinc finger protein, A20, is mediated by kappa B elements. J. Biol. Chem. 267:17971-17976.
70. Tewari, M., F.W. Wolf, M.F. Seldin, K.S. O'Shea, V.M. Dixit, and L.A. Turka. 1995. Lymphoid expression and regulation of A20, an inhibitor of programmed cell death. J. Immunol. 154:1699-1706.
71. Mackman, N. 1995. Regulation of the tissue factor gene. FASEB (Fed. Am. Soc. Exp. Biol.) J. 9:883-889.